Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Molina Healthcare, Inc. due to allegations of violations of federal securities laws related to misleading statements and undisclosed adverse facts affecting the company's financial performance [2][5]. Summary by Sections Legal Investigation - Faruqi & Faruqi, LLP is encouraging investors who suffered losses in Molina to contact them regarding their legal options, particularly for those who purchased securities between February 5, 2025, and July 23, 2025 [1][2]. Allegations Against Molina - The complaint alleges that Molina and its executives made false or misleading statements and failed to disclose critical information, including: - Material adverse facts regarding the company's medical cost trend assumptions [5]. - A dislocation between premium rates and medical costs [5]. - Dependency on low utilization of behavioral health, pharmacy, and inpatient and outpatient services for near-term growth [5]. - Likelihood of substantial cuts to financial guidance for fiscal year 2025 [5]. - Misleading positive statements about the company's business and prospects [5]. Financial Performance and Stock Impact - On July 7, 2025, Molina announced second-quarter financial results, revealing adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures across all business lines. The company cut its full-year adjusted earnings guidance by 10.2%, from at least $24.50 per share to a range of $21.50 to $22.50 per share [6]. - Following this announcement, Molina's stock price fell by $6.97, or 2.9%, closing at $232.61 per share on July 7, 2025, with unusually heavy trading volume [6]. - On July 23, 2025, Molina further slashed its full-year earnings guidance, reporting GAAP net income of $4.75 per diluted share for the second quarter, an 8% decrease year-over-year, and cutting its full-year adjusted earnings guidance to no less than $19.00 per diluted share, representing a 13.6% cut from the previous guidance [7][8]. - This led to a significant drop in Molina's stock price by $32.03, or 16.84%, closing at $158.22 per share on July 24, 2025, also on unusually heavy trading volume [8].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In CarMax To Contact Him Directly To Discuss Their OptionsIf you suffered losses in CarMax between June 20, 2025 and September 24, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile Corp. - November 16, 2025) - Faruqi & Far ...

Core Viewpoint - Baxter International, Inc. is facing a class action lawsuit due to allegations of misleading investors regarding the safety and performance of its Novum LVP device, which has been linked to serious patient risks and malfunctions [2][3]. Group 1: Lawsuit Details - The lawsuit claims that Baxter failed to disclose systemic defects in the Novum LVP that led to malfunctions such as underinfusion and overinfusion, posing serious risks to patients [2]. - Baxter was reportedly aware of multiple device malfunctions, injuries, and deaths associated with the Novum LVP but did not take adequate remedial measures [2]. - The company issued warnings to customers about the risks but continued to face issues with the device, leading to a temporary halt in shipments and installations [3]. Group 2: Financial Impact - Following the announcement of safety concerns and the decision to pause shipments, Baxter's stock price fell by $6.29, approximately 22.4%, from $28.05 to $21.76 on July 31, 2025 [3].

Group 1 - Hormel Foods Corporation is under investigation for possible violations of federal securities laws by Levi & Korsinsky [1] - Hormel Foods has cut its earnings forecast due to price pressures, bird flu, and a fire at its Arkansas peanut butter production facility, leading to a stock drop of over 9% on October 29, 2025 [2] - The company has announced the departure of its Chief Financial Officer amid these challenges [2] Group 2 - Levi & Korsinsky LLP has a strong reputation in securities litigation, having secured hundreds of millions for shareholders and consistently ranking among the top securities litigation firms in the U.S. [3]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against CarMax, Inc. due to alleged violations of federal securities laws, with a deadline for investors to seek lead plaintiff status in a class action lawsuit by January 2, 2026 [1][3]. Financial Performance - CarMax reported a decrease in CarMax Auto Finance income by 11.2%, attributed to a provision for loan losses of $142.2 million in Q2 of fiscal 2026, compared to $112.6 million in the same period the previous year [4]. - The provision for loan losses included an increase of $71.3 million in estimated lifetime losses on existing loans, primarily due to worsening performance among the 2022 and 2023 vintages [4]. - Following the financial results announcement, CarMax's stock price fell by $11.45 per share, approximately 20%, closing at $45.60 per share on September 26, 2025 [4]. Legal Context - The complaint alleges that CarMax and its executives made false and misleading statements regarding the company's growth prospects, which were overstated due to temporary market conditions [3]. - Investors are encouraged to contact Faruqi & Faruqi for more information regarding the class action and to discuss their legal rights [1][5].

Core Viewpoint - Molina Healthcare, Inc. has faced significant challenges, including a substantial earnings miss and a downward revision of its guidance, leading to an investigation regarding potential violations of federal securities laws [1][2]. Financial Performance - Molina reported its third quarter fiscal 2025 earnings significantly below consensus expectations, with a revised full-year earnings forecast of $14 per share, down from a previous estimate of "no less than $19" made in July [2]. - The company's marketplace business performance was identified as a key factor contributing to the earnings shortfall [2]. Stock Market Reaction - Following the earnings announcement, Molina's stock price experienced a sharp decline, falling by $38.08 to open at $157.05 per share [3]. Legal Investigation - Levi & Korsinsky has initiated an investigation into Molina Healthcare for possible violations of federal securities laws, indicating potential legal challenges ahead for the company [1]. Firm Background - Levi & Korsinsky LLP is a well-established securities litigation firm with a strong track record in representing investors and has been recognized as one of the top securities litigation firms in the United States [4].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against James Hardie Industries plc due to allegations of misleading investors regarding the performance of its North America Fiber Cement segment between May 20, 2025, and August 18, 2025 [5][2]. Group 1: Legal Investigation - The firm is encouraging investors who suffered losses in James Hardie to contact them directly to discuss their legal options [1]. - A federal securities class action has been filed against James Hardie, with a deadline of December 23, 2025, for investors to seek the role of lead plaintiff [2][7]. - The complaint alleges that James Hardie and its executives violated federal securities laws by making false statements about the strength of their key segment while being aware of destocking inventory by distributors [5]. Group 2: Financial Impact - On August 19, 2025, James Hardie reported a 29% decline in first-quarter profit and projected lower-than-expected fiscal 2026 earnings due to high borrowing costs [5]. - Following the announcement of these financial results, the price of James Hardie's American Depositary Receipt (ADR) fell by $9.79, or 34.44%, closing at $18.64 per ADR on August 20, 2025 [6]. Group 3: Company Background - Faruqi & Faruqi, LLP is a national securities law firm with a history of recovering hundreds of millions of dollars for investors since its founding in 1995 [4].

NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class lawsuit on behalf all purchasers or acquirers of Six Flags Entertainment Corporation (f/k/a CopperSteel HoldCo, Inc.) (NYSE: FUN) common stock pursuant or traceable to the company’s registration statement and prospectus issued in connection with the July 1, 2024 merger of legacy Six Flags Entertainment Corporation (“Legacy Six Flags”) with Cedar Fair, L.P. (“Cedar Fair”), has been filed in ...

Nov 12, 2025 6:20 PM Eastern Standard Time Lawsuit Filed Against Stride, Inc. (LRN) After Shares Plummet Over 51% Share Investors Urged to Contact Award-Winning Firm, Gibbs Mura Then, on November 11, 2025, a class action lawsuit was filed against Stride, Inc., alleging that the company made claims that were materially false and misleading, ultimately causing harm to investors. According to the complaint, Stride represented to investors that it was "one of the nation's most successful technology- based educa ...

Core Viewpoint - RCI Hospitality Holdings, Inc. is facing legal challenges due to allegations of tax fraud and bribery, which have significantly impacted its stock price [2][3]. Group 1: Legal Issues - RCI is accused of engaging in tax fraud and bribery to conceal this fraud, leading to an understatement of the legal risks facing the company [2]. - On September 16, 2025, New York State Attorney General Letitia James announced indictments against RCI executives for a multimillion-dollar tax fraud scheme and bribery of a state tax auditor [3]. Group 2: Stock Price Impact - Following the announcement of the indictments, RCI's stock price dropped by $5.53 per share, or 16%, closing at $28.79 on September 16, 2025 [3]. - The stock continued to decline the next day, falling an additional $2.99, or 10.38%, to close at $25.80 per share on September 17, 2025 [3].